Table 2.
Confirmed molecular disease: | PRF1 mutation, UNC13D, Munc 18-2, Rab27a, STX11, SH2D1A, BIRC4 |
---|---|
Five of eight clinical and laboratory criteria: | 1. Fever |
2. Splenomegaly | |
3. Cytopenia affecting two or more cell lines: | |
• Hemoglobin <9g/dL | |
• Platelets <100,000/mL | |
• Neutrophils <1000/mL | |
4. Hypertriglyceridemia (fasting triglycerides >265mg/dL or 3mMol/L) and or hypofibrinogenemia (<150mg/dL) | |
5. Hemophagocytosis in bone marrow, spleen, liver, lymph node, skin | |
6. Decreased or absent natural killer cell activity | |
7. Ferritin >500ng/mLa | |
8. Soluble CD25 >2400U/mL |
aFerritin greater than 10,000ng/mL is almost confirmatory.